SECsense Logo

Blueprint Medicines Corporation 8-K Report: Key Insights & Updates

$BPMC
Form 8-K
Filed on: 2025-01-13
Source
Blueprint Medicines Corporation 8-K Report: Key Insights & Updates

Based on the provided XML section of the financial report, here are the key insights extracted:

  1. Company Information:
  • Name: Blueprint Medicines Corporation
  • CIK Number: 0001597264
  • SEC Central Index Key (CIK): This identifier is critical for locating company filings with the SEC.
  • Address: 45 Sidney Street, Cambridge, MA 02139
  • Phone Number: 617-374-7580
  1. Filing Details:
  • Filing Type: 8-K (This form is used to report unscheduled material events or corporate changes that are of importance to shareholders.)
  • Filing Date: January 13, 2025
  1. Security Information:
  • Stock Symbol: BPMC
  • Exchange: NASDAQ
  • Common Stock Par Value: $0.001 per share
  1. Period Information:
  • Reporting Period: The report covers a specific date, January 13, 2025.
  1. Document Reference:
  • Schema Reference: The document refers to a specific schema for XBRL (eXtensible Business Reporting Language) compliance, indicated by the schemaRef attribute.

Insights:

  • The filing is classified as an 8-K, which suggests that significant news or events related to Blueprint Medicines Corporation were reported on January 13, 2025. This could involve changes in management, financial performance, mergers, or other impactful events.
  • The low par value of the common stock ($0.001) may indicate a strategy to attract more investors or facilitate stock options and other employee incentives.
  • Investors and analysts would need to review the content of the 8-K in detail to understand the specifics of the events reported, as this could have implications for stock performance and corporate strategy.

This extracted information provides a foundational understanding of the company's recent activities as reported in the SEC filing.